PUBLISHER: The Business Research Company | PRODUCT CODE: 1946652
PUBLISHER: The Business Research Company | PRODUCT CODE: 1946652
Ophthalmology is a medical specialty that focuses on the diagnosis, treatment, and prevention of eye diseases and disorders affecting the visual system. Ophthalmic devices are utilized for the diagnosis and treatment of various eye conditions. Ophthalmologists are medical doctors who specialize in eye care, performing eye exams, prescribing corrective lenses, diagnosing eye diseases, and conducting surgical procedures to address vision-related issues.
The primary categories within the field of ophthalmic devices include vision care devices and equipment, cataract surgery devices and equipment, refractive surgery devices and equipment, and diagnostic and monitoring ophthalmic devices and equipment. Cataract surgery devices and equipment, for example, involve the use of devices that emit ultrasound waves to soften and break up the lens, making it easier to remove through suction. Expenditure in this domain can come from both public and private sources, and the products used encompass instruments/equipment and disposables. Ophthalmic devices serve a wide range of end users, including hospitals and clinics, diagnostic laboratories, and other healthcare facilities.
Tariffs are impacting the ophthalmic devices market by increasing costs of imported optical components, imaging sensors, laser systems, surgical instruments, and diagnostic equipment used across eye care applications. Hospitals and eye care centers in North America and Europe are most affected due to reliance on imported precision optics and electronics, while Asia-Pacific faces cost pressures on manufacturing and exports. These tariffs are increasing equipment costs and slowing replacement cycles. However, they are also encouraging domestic production of ophthalmic instruments, regional optical manufacturing, and innovation in cost-effective eye care technologies.
The ophthalmic devices market research report is one of a series of new reports from The Business Research Company that provides ophthalmic devices market statistics, including ophthalmic devices industry global market size, regional shares, competitors with a ophthalmic devices market share, detailed ophthalmic devices market segments, market trends and opportunities, and any further data you may need to thrive in the ophthalmic devices industry. This ophthalmic devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The ophthalmic devices market size has grown strongly in recent years. It will grow from $47.31 billion in 2025 to $51.1 billion in 2026 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to rising prevalence of vision impairment, expansion of ophthalmic clinics and hospitals, increasing cataract surgery volumes, growing adoption of corrective vision devices, availability of advanced ophthalmic diagnostics.
The ophthalmic devices market size is expected to see strong growth in the next few years. It will grow to $70.19 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to increasing demand for age-related eye disease treatments, rising adoption of AI-based ophthalmic diagnostics, expansion of outpatient eye surgery centers, growing focus on preventive eye care, increasing investments in ophthalmic technology innovation. Major trends in the forecast period include increasing adoption of advanced diagnostic ophthalmic imaging, rising use of minimally invasive eye surgery devices, growing integration of digital eye examination tools, expansion of laser-based vision correction systems, enhanced focus on early eye disease detection.
The ophthalmic device market is poised for growth, primarily due to the increasing incidence and prevalence of eye diseases. Eye conditions such as age-related macular degeneration (AMD), glaucoma, and cataracts are becoming significant contributors to visual impairment and blindness on a global scale. Ophthalmic devices are indispensable in the diagnosis, treatment, and management of various eye disorders. For instance, in August 2024, according to the National Health Service (NHS), a public sector organization, NHS-funded sight tests reached a record high of over 841,000 in 2024, marking a 6.6% increase compared to 2023. The growing incidence and prevalence of eye-related disorders are expected to drive the demand for ophthalmic devices in the diagnosis and treatment of eye diseases.
Major companies in the ophthalmic devices market are focusing on developing innovative products to maintain their market standing. They invest in research and development to introduce inventive products and expand their market share. For example, in May 2023, Sight Sciences Inc., a U.S.-based eyecare technology company, announced the development of two innovative ophthalmic systems, both featuring proprietary glaucoma and dry eye technologies such as the OMNI Surgical System and the TearCare System. The OMNI Surgical System technology facilitates minimally invasive, implant-free glaucoma procedures for adults with primary open-angle glaucoma, while the TearCare System offers an interventional eyelid procedure for patients with evaporative dry eye disease due to meibomian gland dysfunction through localized heat therapy.
In July 2024, Bausch + Lomb, a US-based eye health company, acquired Trukera Medical, a US-based diagnostic firm, to expand its footprint in the dry eye segment. Through this acquisition, Bausch + Lomb obtained ScoutPro, a portable tear osmolarity device developed by Trukera, enabling improved point-of-care diagnostics for ocular surface disease and dry eye. Trukera Medical is a US-based company that specializes in developing diagnostic solutions for measuring tear-film osmolarity.
Major companies operating in the ophthalmic devices market are Luxottica Group S.p.A., Johnson & Johnson, Hoya Corporation, CooperVision AG, Bausch Health Companies Inc., Carl Zeiss AG, Flex Ltd., Nidek Co. Ltd., Topcon Corporation, Alcon Inc., EssilorLuxottica, Novartis AG, Regeneron Pharmaceuticals Inc., Roche Holding AG, Santen Pharmaceutical Co. Ltd., Rohto Pharmaceutical Co. Ltd., Menicon Co. Ltd., Chengdu Kanghong Pharmaceutical, Glaukos Corporation, STAAR Surgical Company, Omeros Corporation, Aerie Pharmaceuticals Inc., Alimera Sciences Inc., Iridex
North America was the largest region in the global ophthalmic devices market in 2025. Asia-Pacific was the second largest region in the global ophthalmic devices market. Africa. was the smallest region in the global ophthalmic devices market. The regions covered in the ophthalmic devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the ophthalmic devices market report are China, India, Japan, Australia, Indonesia, South Korea, Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, Taiwan, New Zealand, UK, Germany, France, Italy, Spain, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Russia, Czech Republic, Poland, Romania, Ukraine, USA, Canada, Mexico, Brazil, Chile, Argentina, Colombia, Peru, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
The ophthalmic devices consist of sales of instruments such as optical coherence tomography scanners, perimeters/visual field analyzers, ophthalmic pachymeters, wavefront aberrometers, and others. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Ophthalmic Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses ophthalmic devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for ophthalmic devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ophthalmic devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.